Target intelligence / Profile preview

Urinary calcium (UCa)

Target
UCa
Molecular classification
Ion, Inorganic cation, Other
01

Overview

Urinary calcium represents the quantity of calcium ions eliminated through the renal system, serving as a vital indicator of systemic mineral homeostasis and renal function [StatPearls, NBK448183]. It is not a molecular target in the traditional sense, such as a protein or receptor, but rather a clinical analyte used to assess the risk of nephrolithiasis and metabolic bone disorders [Mayo Clinic, 2023]. The excretion of calcium is regulated by a complex interplay of filtration at the glomerulus and reabsorption in various segments of the nephron, influenced by parathyroid hormone, vitamin D, and the calcium-sensing receptor [PubMed, 12623921]. Pharmacological agents such as thiazide diuretics are employed to decrease urinary calcium levels to prevent kidney stones by promoting reabsorption in the distal tubule [PubChem, CID 3639]. Conversely, loop diuretics like furosemide increase calcium excretion and are utilized in treating symptomatic hypercalcemia [StatPearls, NBK532965]. Monitoring urinary calcium is essential for managing conditions like primary hyperparathyroidism, sarcoidosis, and idiopathic hypercalciuria [NIH, 2022].

Other names
Urine calciumUrinary Ca2+24-hour urine calciumCalcium excretion
02

Mechanism of action

Drugs do not directly bind to urinary calcium; instead, they modulate its levels by acting on renal transporters (e.g., Sodium-chloride symporter, Sodium-potassium-chloride cotransporter) or systemic regulators like the Calcium-sensing receptor (CaSR) and Parathyroid hormone (PTH) pathways to alter renal reabsorption and intestinal absorption.

03

Biological functions

Electrolyte homeostasisMineral metabolismRenal excretionOther
04

Disease associations

NephrolithiasisHyperparathyroidismHypoparathyroidismOsteoporosisVitamin D toxicitySarcoidosisOther
05

Safety considerations

Risk of nephrolithiasisNephrocalcinosisHypocalcemiaHypercalcemiaRenal impairmentElectrolyte imbalance
06

Interacting drugs

Hydrochlorothiazide

6 more in the full profile.

07

Biomarkers

24-hour urinary calcium excretionRandom urine calcium-to-creatinine ratioFractional excretion of calcium

Beyond the preview

Go deeper on Urinary calcium (UCa).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urinary calcium (UCa).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call